- Home
- AVIR vs TRX Comparison
AVIR vs TRX Comparison
Compare AVIR & TRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AVIR | TRX |
|---|---|---|
| Founded | 2012 | 1990 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 236.7M | 228.9M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | AVIR | TRX |
|---|---|---|
| Price | $3.18 | $0.85 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $6.00 | $1.25 |
| AVG Volume (30 Days) | 415.4K | ★ 1.3M |
| Earning Date | 11-12-2025 | 01-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.00 |
| Revenue | N/A | ★ $57,613,000.00 |
| Revenue This Year | N/A | $28.16 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $350.73 |
| Revenue Growth | N/A | ★ 39.98 |
| 52 Week Low | $2.46 | $0.27 |
| 52 Week High | $4.02 | $0.89 |
Technical Indicators
Market Signals| Indicator | AVIR | TRX |
|---|---|---|
| Relative Strength Index (RSI) | 53.08 | 67.66 |
| Support Level | $2.99 | $0.70 |
| Resistance Level | $3.24 | $0.89 |
| Average True Range (ATR) | 0.09 | 0.05 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 79.03 | 85.97 |
Price Performance
Historical ComparisonAbout AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About TRX TRX Gold Corporation
TRX Gold Corp is a mineral resource company. It is engaged in the acquisition of interests and the exploration of natural resource properties. Its mineral properties are located in the United Republic of Tanzania. The company's main area of interest has been in the exploration and development of gold properties. It is focused on the Buckreef Gold Project which comprises five prospects, namely Buckreef, Bingwa, Tembo, Eastern Porphyry, and Buziba.